Other notable targets include PLN (phospholamban), involved in calcium handling abnormalities in dilated cardiomyopathy (DCM), and RBM20, a gene associated with RNA splicing defects in heart failure. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.